Small Interfering RNA Targeting Bcl-2 Sensitizes Malignant Melanoma-Reference-Cited by-同舟云学术

Small Interfering RNA Targeting Bcl-2 Sensitizes Malignant Melanoma

Published:2003-10 Issue:5 Volume:13 Page:393-400
ISSN:1545-4576
Container-title:Oligonucleotides
language:en
Short-container-title:Oligonucleotides

Author:

Wacheck Volker¹,Losert Doris¹,Günsberg Patrick¹,Vornlocher Hans-Peter²,Hadwiger Philipp³,Geick Anke⁴,Pehamberger Hubert⁵,Müller Markus¹,Jansen Burkhard¹

Affiliation:

1. Department of Clinical Pharmacology, Section of Experimental Oncology/Molecular Pharmacology

2. Ribopharma AG, D-95326 Kulmbach, Germany

3. Ribopharma AG, D-95326 Kulmbach, Germany. 4Prostate Centre, University of British Columbia, V5Z

4. Ribopharma AG, D-95326 Kulmbach, Germany V5Z

5. Department of Dermatology, Division of General Dermatology, University of Vienna, A-1090 Vienna, Austria

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/154545703322617078

Reference18 articles.

1. bcl-2 Protein Expression in Cutaneous Malignant Melanoma and Benign Melanocytic Nevi

2. The role of the Bcl-2 protein family in cancer

3. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

4. Bcl-2 expression in metastatic malignant melanoma. Importance for the therapeutic efficacy of biochemotherapy

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A folic acid-modified non-viral vector combines gene therapy with chemotherapy to reverse cancer chemotherapy resistance;Applied Materials Today;2021-11

2. BCL2L10 Is Overexpressed in Melanoma Downstream of STAT3 and Promotes Cisplatin and ABT-737 Resistance;Cancers;2020-12-30

3. MicroRNA-24-1-5p promotes malignant melanoma cell autophagy and apoptosis via regulating ubiquitin D;Molecular Medicine Reports;2017-09-26

4. Bcl-2 confers survival in cisplatin treated cervical cancer cells: circumventing cisplatin dose-dependent toxicity and resistance;Journal of Translational Medicine;2015-10-16

5. Inhibition of pulmonary cancer progression by epidermal growth factor receptor-targeted transfection with Bcl-2 and survivin siRNAs;Cancer Gene Therapy;2015-04-10